Yersinia pseudotuberculosis Exploits CD209 Receptors for Promoting Host Dissemination and Infection by He, Ying-Xia et al.
Yersinia pseudotuberculosis Exploits CD209 Receptors for
Promoting Host Dissemination and Infection
Ying-Xia He,a Cheng-Lin Ye,a Pei Zhang,a Qiao Li,a Chae Gyu Park,b Kun Yang,c Ling-Yu Jiang,a Yin Lv,a Xiao-Ling Ying,a
Hong-Hui Ding,a Hong-Ping Huang,a John Mambwe Tembo,a,d An-Yi Li,a Bing Cheng,a Shu-Sheng Zhang,e Guo-Xing Zheng,e
Shi-Yun Chen,f Wei Li,g Lian-Xu Xia,g Biao Kan,g Xin Wang,g Huai-Qi Jing,g Rui-Fu Yang,h Hua Peng,i Yang-Xin Fu,j
John D. Klena,k Mikael Skurnik,l Tie Chena
aDepartment of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, China
bLaboratory of Immunology, Brain Korea 21 PLUS Project for Medical Science, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul,
Republic of Korea
cDepartment of Pathogen Biology and Immunology, Shihezi University School of Medicine, Shihezi, Xinjiang, China
dDepartment of Paediatrics & Child Health, The University of Zambia–University College London Medical School at Zambia, Lusaka, Zambia
eDepartment of Biomedical Science, College of Medicine-Rockford, University of Illinois at Chicago, Rockford, Illinois, USA
fKey Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China
gDepartment of Diarrheal Diseases, National Institute for Communicable Diseases Control and Prevention, Beijing, China
hState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China
iKey Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
jDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
kCenters for Disease Control and Prevention, Atlanta, Georgia, USA
lDepartment of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
ABSTRACT Yersinia pseudotuberculosis is a Gram-negative enteropathogen and causes
gastrointestinal infections. It disseminates from gut to mesenteric lymph nodes (MLNs),
spleen, and liver of infected humans and animals. Although the molecular mechanisms
for dissemination and infection are unclear, many Gram-negative enteropathogens pre-
sumably invade the small intestine via Peyer’s patches to initiate dissemination. In this
study, we demonstrate that Y. pseudotuberculosis utilizes its lipopolysaccharide (LPS) core
to interact with CD209 receptors, leading to invasion of human dendritic cells (DCs) and
murine macrophages. These Y. pseudotuberculosis-CD209 interactions result in bacterial
dissemination to MLNs, spleens, and livers of both wild-type and Peyer’s patch-
deﬁcient mice. The blocking of the Y. pseudotuberculosis-CD209 interactions by ex-
pression of O-antigen and with oligosaccharides reduces infectivity. Based on the
well-documented studies in which HIV-CD209 interaction leads to viral dissemina-
tion, we therefore propose an infection route for Y. pseudotuberculosis where this
pathogen, after penetrating the intestinal mucosal membrane, hijacks the Y.
pseudotuberculosis-CD209 interaction antigen-presenting cells to reach their target
destinations, MLNs, spleens, and livers.
KEYWORDS Yersinia pseudotuberculosis, dendritic cells, DCs, DC-SIGN, CD209a, SIGN-
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Yersinia pseudotuberculosis is a Gram-negative enteropathogen that usually causesfood-borne gastrointestinal infections in humans and animals. It belongs to the
genus Yersinia, which includes 17 different species (1), of which Y. enterocolitica and Y.
pestis cause gastroenteritis and plague, respectively (2–5), and Y. ruckeri causes enteric
red mouth disease of salmonid ﬁsh (6). Y. pestis has evolved from Y. pseudotuberculosis
within the last 10,000 to 20,000 years (7–9). The ability to disseminate to and infect the
regional lymph nodes is a characteristic hallmark of Y. pseudotuberculosis infection (10).
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Y. pseudotuberculosis disseminates to mesenteric lymph nodes (MLNs) directly from a
replicating bacterial pool in the intestinal lumen (11). However, the molecular mecha-
nisms and host cells involved in dissemination of Y. pseudotuberculosis to MLNs remain
to be determined. On the other hand, the mechanisms used by Salmonella for dissem-
ination have been studied, as outlined in an excellent review article (12). Salmonella
spp. appear to utilize antigen-presenting cells (APCs), such as dendritic cells (DCs), as a
carrier to reach the MLNs, after either penetrating the mucosal membranes or passing
through the Peyer’s patches (12, 13). While the molecular mechanisms of the DC-
associated dissemination of Salmonella are still unknown, it was shown that the core
region of the lipopolysaccharide interacts with the human DC-SIGN (hDC-SIGN; CD209)
receptor of DCs (14). DC-SIGN is also a receptor of HIV that hijacks the DCs to promote
viral dissemination to target cells, such as CD4 lymphocytes in lymph nodes (15, 16).
Over 70% of the surface of Gram-negative bacteria is occupied by lipopolysaccha-
ride (LPS), which generally consists of three structural regions: (i) lipid A, (ii) the
oligosaccharide core, and (iii) the O-polysaccharide (OPS) or O-antigen (O-ag) (Fig. 1).
LPS produced by smooth bacteria is known as smooth LPS, while LPS lacking O-ag is
known as rough LPS or lipooligosaccharide (LOS). O-ag is a virulence factor of Y.
pseudotuberculosis; however, its production is suppressed in bacteria grown at 37°C
(17–19), suggesting also that the LPS core would be exposed in bacteria growing in vivo
(Fig. 1). The apparent question, then, is why Y. pseudotuberculosis would subdue the
production of O-ag, its virulence factor, during infection.
Both Y. pseudotuberculosis and Salmonella are enteropathogens; therefore, we asked
if the LPS core of Y. pseudotuberculosis also interacts with DC-SIGN and, if so, whether
this interaction would lead to the dissemination of Y. pseudotuberculosis to MLNs. Y.
pseudotuberculosis, after overcoming the ﬁrst line of host defense, the mucosal mem-
FIG 1 Structures of inner core and outer core regions of the LPS or LOS of E. coli K-12, S. enterica serovar
Typhimurium, Y. pestis, and Y. pseudotuberculosis and the genes involved in their biosynthesis. Genes
involved in the biosynthesis of core LPS are shown at their approximate site of action (solid line). The sites
that are variably substituted or still under investigation are indicated by dashed lines. Abbreviations:
GlcNAc, N-acetylglucosamine; Glc, glucose; Hep, L-glycero-D-manno-heptose; Gal, galactose; P, phos-
phate; PPEtn, phosphoethanolamine; KDO, 2-keto-3-deoxyoctonate. It should be noted that E. coli K-12
and Y. pestis naturally do not possess an O-antigen.
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brane of the small intestine, with the help of the virulence factors invasin (20, 21) and
Ail (22–24), encounters in the intestinal tissue secondary host defense systems such as
DCs and macrophages. Here, we present evidence that rough LPS-producing Y. pseu-
dotuberculosis exploits APCs via LOS (rough LPS)-CD209 interaction as a means to
disseminate to lymph nodes, spleen, and liver to initiate host infection.
RESULTS
Peyer’s patches may not play a major role in dissemination of Y. pseudotuber-
culosis. One of the dissemination mechanisms used by Salmonella involves passage
through Peyer’s patches (12, 13). To examine whether the dissemination of Y. pseudo-
tuberculosis involves the Peyer’s patches, we used a Peyer’s patch-deﬁcient mouse
model carrying a deletion of the lymphotoxin-LTR-1 gene (25). Figure 2 shows that
dissemination of the Y. pseudotuberculosis strain YPIII bacteria to MLNs, livers, and
spleens was not reduced in the Peyer’s patch-deﬁcient mice, suggesting that Peyer’s
patches do not play a major role in dissemination of Y. pseudotuberculosis. It should be
noted that MLNs are also underdeveloped in the LTR-1 knockout (KO) mice (25).
hDC-SIGN and murine SIGNR1 (mSIGNR1) are receptors for phagocytosis of Y.
pseudotuberculosis. If Peyer’s patches were not the dissemination route of Y. pseudotu-
berculosis, the pathogen, after passage through the mucosal membrane, encounters the
secondary host defense system, including DCs and macrophages. Given that Y. pseudotu-
berculosis produces rough LPS (LOS) when grown at 37°C (17–19), we examined the
interactions of APCs with Y. pseudotuberculosis bacteria grown at 37°C and at 26°C.
(i) Y. pseudotuberculosis bacteria cultured at 37°C but not at 26°C invade
human dendritic cells and mouse macrophages. We ﬁrst examined the ability of Y.
pseudotuberculosis strain Y1 bacteria grown at 37°C or 26°C to invade human DCs and
mouse macrophages. The Escherichia coli K-12 strain CS180 (with rough LPS) and
CS1861 (CS180 derivative with smooth LPS) bacteria were used as controls (14, 26). The
gentamicin protection assay (Fig. 3A and C) and ﬂow cytometry (Fig. 3B and D)
experiments showed that Y1 bacteria cultured at 37°C invaded human DCs and
macrophages much more effectively than Y1 bacteria cultured at 26°C. The results
suggest that lack of O-ag on Y1 bacteria grown at 37°C contributes to the invasion of
human DCs and mouse macrophages.
(ii) Y. pseudotuberculosis Y1 cultured at 37°C but not at 26°C promotes hDC-
SIGN- and mSIGNR1-mediated invasion of host cells. hDC-SIGN is a receptor for E.
coli and other Gram-negative bacteria with rough-type LPS (14, 26). Furthermore, we
have unpublished evidence suggesting that the Y. pestis LOS uses the mouse SIGNR1,
not the mouse DC-SIGN, SIGNR3, or langerin (mCD207), as a receptor. To investigate
whether human DC-SIGN and mouse SIGNR1 were responsible for the interaction of
human DCs and mouse macrophages, stably transfected cell lines expressing human
DC-SIGN (HeLa-hDC-SIGN) and murine SIGNR1 (CHO-mSIGNR1) were tested for their
FIG 2 Dissemination of Y. pseudotuberculosis in Peyer’s patch-deﬁcient mice. Wild-type and lymphotoxin-
LTR-1-deleted mice (25) were orally infected with 108 CFU of Y. pseudotuberculosis YPIII (37). The dissemi-
nation rate (bacterial load) in the spleens, livers, and MLNs was quantiﬁed at 72 h after infection. *, P 0.05.
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ability to phagocytose Y1 bacteria grown at 37°C and 26°C (37-Y1 and 26-Y1, respec-
tively). Again, E. coli CS180 and CS1861 bacteria were used as controls.
Two observations were made from these experiments (Fig. 4). First, 26-Y1 bacteria
invaded all cells (HeLa, HeLa-hDC-SIGN, CHO, and CHO-mSIGN-R1) at similar rates,
indicating that neither hDC-SIGN nor mSIGNR1 was necessary for the invasion. In Y.
pseudotuberculosis, three invasion factors, invasin, YadA, and Ail, participate in the
host-pathogen interactions (21, 23, 27). Very likely, the very effective hDC-SIGN/
mSIGNR1-independent interaction with HeLa and CHO cells (Fig. 4A and B) is mediated
by interaction between invasin and its receptor, -integrin, which is expressed on most
epithelial cells (20, 21). Second, 37-Y1 bacteria invaded HeLa-hDC-SIGN (Fig. 4A) and
CHO-mSIGNR1 (Fig. 4B) cells more effectively than HeLa-Neo and CHO-Neo cells. It
FIG 3 Y. pseudotuberculosis cultured at 37°C but not 26°C invades human DCs and murine macrophages. Gentamicin protection- and ﬂow cytometry-based
assays were used to determine the DC invasion rates of Y. pseudotuberculosis Y1. E. coli K-12 strains (CS180 and CS1861) were utilized as controls. (A and C)
Data from the gentamicin protection assay. (B and D) Data from ﬂow cytometry. DCs and macrophages incubated with labeled and unlabeled bacteria are
indicated by open and ﬁlled curves, respectively. Y. pseudotuberculosis organisms cultured at 37°C and 26°C are referred to as 37-Y1 and 26-Y1, respectively.
***, P  0.001.
FIG 4 HeLa-hDC-SIGN and CHO-mSIGNR1 transfectants phagocytose Y. pseudotuberculosis grown at 37°C. The phagocy-
tosis of two pairs of bacteria, E. coli K-12 (CS180 and CS1861) and Y. pseudotuberculosis Y1, cultured at 26°C and 37°C with
HeLa/HeLa-hDC-SIGN (A) and CHO/CHO-mSIGNR1 (B), was performed by incubating cell lines for 2 h with indicated
bacterial strains and by killing the extracellular bacteria with gentamicin as described in Materials and Methods. The
number of phagocytosed bacteria was determined by counting CFU recovered following gentamicin treatment. ***, P 
0.001.
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should be noted that the invasion rate of 37-Y1 bacteria into HeLa cells was lower than
that of 26-Y1 bacteria, as invasin expression is repressed at 37°C (28).
Based on the evidence described above, we conclude that hDC-SIGN and mSIGNR1
function as receptors and contribute to the phagocytosis of 37-Y1 in cell lines.
The LPS core of Y. pseudotuberculosis serves as a ligand. The data described
above revealed similar invasion patterns of HeLa-hDC-SIGN and CHO-mSIGNR1 cells for
E. coli CS180 and 37-Y1. Since the LPS core of E. coli is a ligand for hDC-SIGN (26), we
speculated that the interaction of 37-Y1 bacteria with hDC-SIGN and mSIGNR1 would
also be due to the exposed LPS core.
To conﬁrm this hypothesis, we tested the interaction of two isogenic pairs of
Y. pseudotuberculosis strains, PB1 and PB1Δwb strains and PB1ΔailΔinv and
PB1ΔwbΔailΔinv strains, with human DCs (Fig. 5A), mouse macrophages (Fig. 5B),
HeLa or HeLa-hDC-SIGN cells, and CHO or CHO-mSIGN-R1 cells (Fig. 6A and B). It should
be noted that the wild-type Y. pseudotuberculosis strain PB1 produces smooth LPS, and
its PB1Δwb rough isogenic derivative produces LOS (29, 30). In addition, for this
experiment, the virulent plasmid in PB1 and its isogenic derivatives was deleted.
FIG 5 Human DCs and mouse macrophages phagocytose the deﬁned rough Y. pseudotuberculosis. The phagocytosis of Y. pseudotuberculosis by human DCs
(A) and mouse macrophages (B) followed the same procedures as those described in the legend to Fig. 3. The two strains used were the smooth LPS-producing
Y. pseudotuberculosis PB1 and its isogenic rough derivative, the PB1Δwb strain, lacking the O-ag. (A and B) Data from the gentamicin protection assay. (C) Data
from ﬂow cytometry. DCs and macrophages with labeled and unlabeled bacteria are indicated by open and ﬁlled curves, respectively. ***, P  0.001.
FIG 6 Human DC-SIGN and mouse SIGNR1 transfectants phagocytose the rough Y. pseudotuberculosis. The invasion of HeLa-hDC-SIGN (A) and CHO-mSIGNR1
(B) with PB1/PB1wb and PB1ailinv/PB1wbailinv strains followed the same procedures as described for Fig. 4. ***, P  0.001.
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As shown in Fig. 6, the rough PB1Δwb bacteria with or without an inv- and
ail-deleting background, even when grown at 26°C, promoted the very typical core-
mediated interaction with hDC-SIGN (26) and mSIGNR1, whereas the smooth PB1 did
not. Taken together, the ability of rough Y. pseudotuberculosis to interact with human
DCs, mouse macrophages, HeLa-hDC-SIGN, and CHO-mSIGN-R1 cells is most likely due
to interactions between the exposed LPS core and hDC-SIGN and mSIGN-R1.
The interactions between LPS core and hDC-SIGN/mSIGN-R1 were inhibited by
additions of anti-hDC-SIGN/mSIGN-R1, mannan, and LPS core oligosaccharides. To
conﬁrm that LPS core of Y. pseudotuberculosis is involved in the interaction, we
examined whether the interactions of HeLa-hDC-SIGN and CHO-mSIGN-R1 transfec-
tants with rough Y. pseudotuberculosis could be inhibited by anti-hDC-SIGN antibody,
anti-mSIGN-R1 antibody, mannan, which speciﬁcally binds mannose-related receptors,
and LPS core. Anti-CD66 antibody was used as a control antibody. As shown in Fig. 7A
and B, the invasion of HeLa-hDC-SIGN and CHO-mSIGNR1 by the PB1Δwbailinv strain
was blocked by addition of all three inhibitors.
Although the anti-hDC-SIGN, mannan, and LPS core failed to show any signiﬁcant
impact on the phagocytosis of Y. pseudotuberculosis of the PB1Δwbailinv strain,
when used separately (Fig. 8), this hDC-rough Y. pseudotuberculosis interaction showed
a reduction when the triple reagents were applied. In our previous studies, we found
that anti-DC-SIGN antibody alone cannot effectively inhibit the LPS core-mediated
phagocytosis of E. coli, Neisseria gonorrhoeae, and Y. pestis by DCs (14, 26, 31–33). We
speculated that other receptors also are involved in the phagocytosis of the core-
exposed Gram-negative bacteria. Details are addressed in Discussion.
The LPS core-mediated phagocytosis of Y. pseudotuberculosis by macrophages
occurs in vivo. While it is clear that the LPS core participates in the in vitro interaction
of Y. pseudotuberculosis with APCs, it remained to be elucidated whether this interac-
tion also occurs in vivo. To this end, we injected bacterial suspensions directly into the
intraperitoneal cavity of live mice. This approach is analogous to our previous study
showing that the interaction of mouse CD205 (DEC-205) receptor on alveolar macro-
phages with the Y. pestis plasminogen activator (Pla) occurs in vivo (34). The intraperi-
toneal exudate was collected from the mice 1.5 h after the infection and placed in
gentamicin medium to kill the extracellular bacteria. Figure 9 shows that a higher
percentage of the PB1Δwb bacteria than of the wild-type PB1 strains were intracellular
and, thus, protected from gentamicin killing.
The data suggest that the LPS core interaction with mSIGNR1 had mediated
phagocytosis of Y. pseudotuberculosis by macrophages in vivo.
FIG 7 Phagocytosis of Y. pseudotuberculosis PB1wbailinv strain by HeLa-DC-SIGN and CHO-mSIGN-R1 was blocked by anti-hDC-SIGN
antibody, anti-mSIGN-R1 antibody, mannan, and LPS core. (A) Pretreated HeLa-NEO and HeLa-hDC-SIGN cells with anti-hDC-SIGN
antibody, mannan, and LPS core were incubated for 2.5 h with the Y. pseudotuberculosis PB1wbailinv strain. Bacterial phagocytosis
was measured as described in Materials and Methods. (B) Pretreatment of cells with anti-mSIGN-R1 antibody, mannan, and LPS core
blocked phagocytosis of the Y. pseudotuberculosis PB1wbailinv strain to CHO-mSIGN-R1. P 0.001.
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The exposure of the LPS core enhances the dissemination of Y. pseudotuber-
culosis to MLNs, spleen, and liver. We have demonstrated here that Y. pseudotuber-
culosis, when grown at 37°C, uses its LPS core to interact with hDC-SIGN and mSIGNR1
receptors, leading to the invasion of APCs in vitro and in vivo. We therefore hypothe-
sized that the dissemination of Y. pseudotuberculosis to the MLNs, spleens, and livers
would also be a result of this host-pathogen interaction. Subsequently, shielding the
exposed LPS core of Y. pseudotuberculosis grown in vivo at 37°C should reduce the
dissemination of the bacteria to MLNs, spleens, and livers.
(i) Higher numbers of rough than smooth Y. pseudotuberculosis bacteria were
disseminated to MLNs, spleens, and livers. To achieve a Y. pseudotuberculosis strain
producing smooth LPS in vivo, we introduced plasmid pAY100.1 into strain Y1. Plasmid
pAY100.1 carries the O-ag gene cluster of Y. enterocolitica serotype O:3 and produces
the O-ag irrespective of the growth temperature (31, 32, 34–36). As a control, the
plasmid vector pBR322 was transformed to Y1. Mice were infected via the orogastric
route with Y1/pBR322 and Y1/pAY100.1 bacteria and sacriﬁced after 72 h. MLNs, livers,
and spleens were then recovered and homogenized. The dissemination rates of the
FIG 8 Reduction of phagocytosis of Y. pseudotuberculosis PB1wbailinv strain by DCs in the presence
of anti-DC-SIGN, mannan, and LPS core together. Besides the addition of anti-hDC-SIGN, mannan, and
LPS core, the procedures followed were the same as those described for DCs in the legend to Fig. 5A.
P 0.001 by two-way ANOVA comparing the interaction of DCs with Y. pseudotuberculosis
PB1wbailinv strain in the presence of anti-hDC-SIGN, mannan, and LPS core to the interaction in the
absence of antibody.
FIG 9 Interaction of the LPS core with macrophages occurs in vivo. Bacterial suspensions of PB1Δwb and
PB1 strains, cultured at 26°C, were inoculated into the intraperitoneal cavity of live mice. After incubation
for 1.5 h, collected macrophages were examined for the rate of internalized bacteria. ***, P  0.001.
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bacteria into the different organs were calculated by counting CFU. Figure 10A and C
shows that higher numbers of Y1/pBR322 than Y1/pAY100.1 bacteria were isolated
from the MLNs, spleens, and livers. Importantly, no differences in bacterial numbers
were observed between the intestinal lumens of Y1/pBR322- and Y1/pAY100.1-infected
mice (Fig. 10D). In addition, both strains exhibited no differences in growth and
adhered to both HeLa and CHO cells equally well (data not shown).
(ii) Higher quantity of bacterial DNA was recovered from MLNs, livers, and
spleens of mice infected with rough than with smooth Y. pseudotuberculosis. The
mice were challenged as described above, but the mice were sacriﬁced after 8 h of
infection. The Y. pseudotuberculosis-speciﬁc DNA in MLNs, livers, and spleens was
quantitated using ail gene-speciﬁc real-time PCR. In all tissues the relative amount of
bacterial DNA was higher in Y1/pBR322- than in Y1/pAY100.1-infected mice (Fig. 10B),
supporting the results of bacterial numbers described above.
In summary, the results suggest that Y. pseudotuberculosis could utilize its LPS core
to interact with CD209 to enhance dissemination to the host tissues.
Blocking of the LPS core CD209 interaction with mannan or dextran oligosac-
charide reduces the infectivity of Y. pseudotuberculosis. The LPS core CD209
interaction in E. coli can be blocked in vitro by several oligosaccharides, including
mannan (14). Given that the interactions reported above were mediated by the LPS
core oligosaccharide, we hypothesized that shielding the exposed LPS core with
CD209-interacting oligosaccharides could reduce the bacterial infectivity in a murine
model. To this end, we tested the inﬂuence of mannan and dextran oligosaccharides on
the infectivity of the wild-type and fully virulent Y. pseudotuberculosis strain YPIII (37).
The body weights and the mortality of the mice were monitored. The results clearly
demonstrated that both the body weight loss (Fig. 11A) and mortality rate (Fig. 11B) of
mice infected with YPIII in the presence of mannan or dextran oligosaccharides were
FIG 10 Dissemination of Y. pseudotuberculosis was inhibited when covered with O-ag. Mice were infected orogastrically with 108 CFU of Y1/pBR322 or
Y1/pAY100.1, and bacterial loads in the spleens, livers, and MLNs were quantiﬁed at 72 h postinfection. (A) For CFU counting, the homogenized samples of
organs were spread on LB agar to recover the bacteria. Each circle represents the data obtained for one infected mouse, and horizontal boldface lines indicate
the median values. *, P 0.05. (B) Eight hours after inoculation in the real-time PCR assay, the absolute numbers of bacteria were determined from standard
curves of serial dilutions of Y1 chromosome DNA. Values obtained from three independent measurements represent Y1/pAY100.1 DNA extracted from total
tissue relative to that of Y1/pBR322. ***, P 0.001. (C) After infection with Y1/pBR322-mCherry or Y1/pAY100.1-mCherry, mice were sacriﬁced and the spleens,
livers, MLNs, and intestine were isolated for detection with the IVIS system, as shown in panel D. **, P  0.005.
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signiﬁcantly reduced. It should be noted that the growth rate of the Y. pseudotuber-
culosis YPIII bacteria was not inﬂuenced by the mannan oligosaccharide, as is the case
with other Gram-negative bacteria (14, 26, 33).
In conclusion, these results might help us understand how and why oligosaccharide-
based prevention methods and treatments for certain diarrheal infections work.
DISCUSSION
Y. pseudotuberculosis is able to disseminate and infect MLNs (10). However, the
molecular mechanisms involved in dissemination of Y. pseudotuberculosis to MLNs
remained to be determined. In this work, we demonstrate that the interaction between
LPS core oligosaccharide and CD209 receptors may contribute to this dissemination.
O-ag is a well-documented virulence factor for Y. pseudotuberculosis, but O-ag
production was almost fully suppressed in bacteria grown at 37°C (17–19), suggesting
that during infection the LPS core oligosaccharide of the bacteria was exposed (Fig. 1).
Why would Y. pseudotuberculosis restrain the expression of its virulence factor during
infection? Based on the evidence presented in this work, we speculate that after penetra-
tion through the mucosal membrane of the small intestine, perhaps not via Peyer’s patches
(Fig. 2), Y. pseudotuberculosis intentionally represses O-ag production. This exposes the LPS
core oligosaccharide to interact with CD209. As a result, the bacteria invade the APCs and
are carried by the infected APCs to lymph nodes, spleen, and liver, facilitating the bacteria
to colonize these tissues and establish the host infection.
Thus, an important corollary to this study is that some pathogens, such as Y.
pseudotuberculosis, have evolved mechanisms for exploiting the very host defenses
designed to eliminate them, with the result being an expanded ability to disseminate.
Our unpublished data also indicate that similar to Y. pseudotuberculosis, Salmonella, but
not Shigella, is able to modify its LPS during infection. Consequently, Salmonella is also
able to hijack the APCs in a manner similar to that of Y. pseudotuberculosis.
Certain technical issues need to be discussed here. First, three identiﬁed virulence
factors mediate interactions between Y. pseudotuberculosis bacteria and host cells (21,
23, 27), one of which is invasin. As shown in Fig. 4, Y. pseudotuberculosis cultured at 26°C
interacts with HeLa and CHO cells at a high level, but this interaction was reduced when
Y. pseudotuberculosis was cultured at 37°C, since the expression of invasin at this
temperature is suppressed (28). On the other hand, it appears that invasin does not
participate in or inﬂuence the interaction between Y. pseudotuberculosis and dendritic
cells, because Y. pseudotuberculosis cultured at 37°C invades DCs, but the invasion of DC
by Y. pseudotuberculosis cultured at 26°C is dramatically reduced.
Besides the integrin-invasin interaction, Y. pseudotuberculosis promotes another
hDC-SIGN- or mSIGNR1-independent interaction with HeLa and CHO cells (Fig. 4 and 6).
We have observed that this DC-SIGN-independent interaction appears to rely on the Ail
protein of Yersinia, which may involve the heparan sulfate proteoglycan (our unpub-
FIG 11 Blockage of the host-pathogen interaction with certain oligosaccharides reduces the infectivity by Y. pseudotuberculosis. After
culture at 37°C, wild-type Y. pseudotuberculosis strain YPIII (37) bacteria with or without mannan or dextran were inoculated into mice
by following procedures described in Materials and Methods. The rates of body weight loss (A) and mortality (B) were recorded every
12 h up to 156 h postinfection. Student’s t test was used to determine signiﬁcant differences in both body weight and death of mice
by the wild-type Y. pseudotuberculosis YPIII with and without oligosaccharides, mannan, and dextran. *, P  0.001.
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lished observation) and other binding proteins of ﬁbronectin (38), C4b-binding protein
(39), and vitronectin (40). Fortunately, this interaction can be inhibited by heparin, a
synthetic form of heparan sulfate (31). This is also the reason for the inclusion of heparin
in the experiments intended to observe the interaction between Y. pseudotuberculosis
and HeLa or CHO cells (Fig. 4 and 6).
We showed that a clear inhibition was obtained from transfectants (Fig. 7) but not
in primary cells (Fig. 8). Only the triple reagents of inhibitors (antireceptor antibodies,
mannan oligosaccharide, and puriﬁed LPS core) employed were able to partially inhibit
the interactions of hDCs with Y. pseudotuberculosis. There might be many reasons or
factors involving the interaction in primary cells. (i) As described above, we believe the
interaction between LPS core carbohydrates and C-type lectins results from nonspeciﬁc
bindings, i.e., while some cell lines are capable of these interactions, primary cells are
not. (ii) Human DCs also expressed langerin (CD207), another receptor for HIV, which
was also a receptor for the LPS core (32). (iii) DCs are very dynamic cells that
phagocytose everything they encounter.
We have suggested that suppression of O-ag expression in Y. pseudotuberculosis
enhances its virulence, but the fact is that the expression of O-ag is absolutely
necessary for the pathogenicity based on the recovery of a number of O-ag gene
cluster mutants in signature-tagged mutagenesis experiments (41). Therefore, we used
the Y. pseudotuberculosis strain Y1, grown at 26°C and at 37°C, instead of the PB1 and
PB1Δwb strains to examine the LPS core CD209 interaction-mediated in vivo dissemi-
nation (Fig. 10). For this reason, this study only indicates that in Y. pseudotuberculosis
the O-ag expression is repressed during certain stages of the infection and/or in
different tissues.
DC-SIGN (CD209), langerin (CD207), and DEC-205 (CD205) have been shown to be
receptors for the LPS core ligand of several Gram-negative bacterial species, thereby
promoting bacterial adherence and phagocytosis (14, 26, 31–34). The biological signif-
icance of the host-pathogen interaction has been poorly understood and ill-deﬁned.
The present study provides the ﬁrst instance of a deﬁnition of this interaction and its
possible biological signiﬁcance, which may contribute to future studies in various ﬁelds,
as shown below.
Salmonella spp. rather than Shigella spp. are able to disseminate to other parts of
mammalian organs and cause systemic infections. Ongoing studies in the laboratory
indicate that like Y. pseudotuberculosis, Salmonella spp., but not Shigella spp., are able
to modify their full O-antigen-expressing LPS into O-antigen deletion core LOS during
infection. Consequently, Salmonella spp. (data not shown) are able to hijack the APCs
similarly to the infection caused by Y. pseudotuberculosis, as described in this study. As
shown in our previous report, S. enterica serovar Typhimurium utilizes its core LOS to
interact with human DC-SIGN, resulting in phagocytosis by host cells (14). Interestingly,
a recent report indicated that Shigella spp. are able to disseminate if the expression of
O-antigen or O-antigen-expressing capsule is genetically modiﬁed (42). It should be
recognized that the previous report categorized results for Shigella and E. coli as being
from a single species.
The most signiﬁcant contribution of this study is to reveal a possibly new molecular
mechanism of several persistent infections, including urinary tract infection (UTI) by E.
coli, Gram-negative bacterium-associated Crohn’s disease, typhoid fever, Helicobacter
pylori-associated chronic atrophic gastritis (ChAG), and chronic infection caused by
Klebsiella spp. Although the expression of O-antigen protects the Gram-negative bac-
terial pathogens from phagocytosis and serum killing, the core LOS-expressing bacteria
(rough strains), such as enterohemorrhagic E. coli (EHEC), uropathogenic E. coli (UPEC),
Salmonella spp., Helicobacter pylori, Shigella sonnei, and Y. pseudotuberculosis, are
isolated from clinical samples (14, 26). We expect that the loss of O-antigen or
modiﬁcation of LPS during infection causes the Gram-negative bacteria to become less
virulent but readily phagocytosed by APCs. Thus, the phagocytosed bacteria may hide
themselves from attacks of various host clearance systems, as shown in Salmonella (43).
Mounting data have shown associations among APCs, C-type lectin CD209s, LPS, and
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persistent infections caused by the Gram-negative bacterial pathogens described
above. Hopefully, the data presented in this work will add to the collective understand-
ing.
Y. pseudotuberculosis is an ancestor of several Gram-negative bacteria (7–9, 44, 45),
can live and replicate in various host niches (46), and causes different clinical manifes-
tations (47). Studies of this pathogen during infection may generate a broad impact in
understanding the pathogenesis of bacterial pathogens in general. A new technology,
called dual RNA sequencing (RNA-seq), for monitoring the transcript proﬁles of patho-
gens and hosts during infection has been developed (48). This technology has been
used for proﬁling S. enterica serovar Typhimurium (49), Haemophilus inﬂuenzae (50), and
Mycobacterium tuberculosis (51); these proﬁles were limited to in vitro studies only. With
Y. pseudotuberculosis as the model strain, Nuss et al. further established a fast, generic tissue
dual RNA-seq approach, which allows a broad and instantaneous monitoring of gene
expression that links the infected hosts and the colonizing pathogens in in vivo infection
(52). As a result, they ﬁrst found that one of the main strategies for bacterial survival during
infection was to prevent pathogens from phagocytic attacks (52). Second, they discovered
that Yersinia germs can also reduce the production of toxins that induce the inﬂammation
of the afﬂicted tissues during infection. Therefore, the reduction of inﬂammation allows
bacteria to escape attacks from the host immune system (53). This process is now named
“bacteria persist as stowaways” (https://health.economictimes.indiatimes.com/news/
industry/bacteria-persist-as-stowaways-hzi/62836896). The toxin described here could be
the O-antigen of Y. pseudotuberculosis.
In summary, because this host-pathogen interaction is not restricted to one species,
the ﬁndings presented here may contribute to future, more broad studies, as also
illustrated in the last sentence of a 2006 report (14): “From an evolutionary point of
view, the interaction of bacterial core LOS/LPS and the innate immune receptor,
DC-SIGN, may represent a primitive interaction between microbial pathogens and the
professional phagocytic host cells.”
MATERIALS AND METHODS
Human and animal studies. All animal procedures and human experiments were carried out in strict
accordance with the Institutional Animal Care and Use Committees (IACUCs) and Institutional Review
Board (IRB) of Tongji Hospital, Tongji Medical College, Tongji, China. The handling of the mice and all
experimental procedures were speciﬁcally approved for this study by the Medical Ethics Committee of
Tongji Hospital and were conducted in accordance with institutional guidelines (IRB identiﬁers TJ-
A20141220 for animal experiments and TJC20140113 for human experiments). All procedures on mice
were performed under sodium pentobarbital anesthesia, all efforts were made to minimize suffering, and
all volunteers involved in the experiment signed informed consent.
Bacterial strains. E. coli K-12 strain CS180 produces a rough LPS missing O-ag (54) (Table 1). CS1861
is a derivative of CS180 harboring pSS37, a plasmid containing all of the genes for O-ag expression from
Shigella dysenteriae 1 (54–56) (Fig. 1). E. coli strains were cultured on Luria-Bertani (LB) medium
supplemented with 1.5% agar at 37°C overnight. Y. pseudotuberculosis Y1 is a serotype O:1a strain lacking
the virulence plasmid (pYV). This strain originates from the CDC and has been used as a positive invasion
control previously (57–59). We also used the Y. pseudotuberculosis O:1a wild-type strain PB1 (60) and its
rough isogenic derivative, the PB1Δwb strain, which is unable to produce O-ag due to deletion of the
whole O-ag gene cluster (29). Constructions of inv- and ail-deleting mutants for PB1 are also shown in
Table 1. These strains were grown and maintained in a manner identical to that for E. coli K-12. The
Yersinia strains described above were virulence plasmid-cured strains, selected using a combination of
magnesium oxalate and Congo red selection methods (61). However, Yersinia pseudotuberculosis sero-
type O:3 strain YPIII is a wild-type and fully virulent strain (37) and contains the virulence plasmid.
Construction of Y. pseudotuberculosis that expresses O-ag at 37°C. The lack of O-ag at 37°C in Y.
pseudotuberculosis is due to repression of the O-ag biosynthetic genes (17–19) (Fig. 1). Y. pseudotuber-
culosis strain Y1 was transformed with plasmid pAY100.1, which carries all of the necessary genes for the
expression of the O-ag of Y. enterocolitica serotype O:3 (35, 36). The expression of O-antigen, coded for
by pAY100.1 plasmid, is not inﬂuenced by growth temperature (31, 32, 34). Therefore, this mutant is still
able to express a full LPS even at 37°C.
Construction of Y. pseudotuberculosis PB1 and PB1wb strains with inv and ail gene knockout.
We used two steps to construct the inv- and ail-deleted mutants. First, to knock out the ail gene of Y.
pseudotuberculosis, the suicide plasmid PCVD442-ail::KmGB was mobilized into the Y. pseudotuberculosis
PB1wb strain, as described previously by Ho et al. (62) and our laboratory (unpublished data). Brieﬂy,
the suicide plasmid in E. coli S17-1pir was introduced into the parental Y. pseudotuberculosis PB1wb
strain by conjugation. The Kanr transconjugants were selected using a Yersinia selective agar plate with
cefsulodin-irgasan-novobiocin (CIN) agar for counterselection of the donor. The selected transconjugants
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then were plated onto LB agar with 10% sucrose and grown at room temperature for 2 days. The correct
allelic exchange in the resultant Sucr Kanr colonies was conﬁrmed using PCR with corresponding primers
ailrf1 (5-TCAATGGGGCTATTGATTTCG-3) and ailr1 (5-GGTGACTTGCTCGAAATAATG-3) (63). Replacement of
Ail with a cassette results in a complete deletion of the ail gene. The deletion of the ail gene from the
mutants resulted in the PB1wbail strain.
For generating the inv knockout strain, the CRISPR-Cas12a system was used to delete the inv gene
from the Y. pseudotuberculosis PB1ail and PB1Δwbail strains, as described previously (64, 65). Brieﬂy,
the protospacer adjacent motif (PAM) TTG, a short DNA sequence (3 to 5 bp) adjacent to the protospacer
(target, 25 nucleotides [nt]) site, was selected in the coding sequence of inv. Two complementary
oligonucleotides (crRNA-inv top and crRNA-inv bottom) containing the protospacer sequence (adjacent
to 5=-TTG-3=) were synthesized, annealed to yield a protospacer cassette with BsaI overhangs at the 5=
and 3= ends, and then cloned into the crRNA expression plasmid pAC-crRNA-Cm to generate the
recombinant plasmid pcrRNA-inv-Cm. A single-stranded DNA (ssDNA) oligonucleotide (inv oligonucleo-
tide for lagging) with 40 nt of ﬂanking region sequence identity on both sides of the mutation site was
synthesized, in which 3 termination codons (TAA TGA TAG) and a 22-nt random sequence were
introduced between the 2 ﬂanking regions. Cotransformation of the ssDNA oligonucleotides and the
recombinant plasmid pcrRNA-inv-Cm into Y. pseudotuberculosis PB1ail and PB1Δwbail cells harboring
pKD46-cpf1(Cas12a) was performed, and samples were plated on LB supplemented with 100 g/ml
ampicillin and 30 g/ml chloramphenicol and incubated at 26°C. Single colonies were plucked to
inoculate LB medium supplemented with appropriate antibiotics at 26°C. We performed PCR on the
target gene regions with corresponding primers to screen preliminarily and sent the PCR products for
sequencing to verify the PB1ailΔinv and PB1Δwbailinv clones. Finally, the pcrRNA-inv-Cm plasmid
and pKD46-cpf1 plasmid were cured by incubation on an LB plate with 7% sucrose and incubation in LB
medium at 42°C with shaking overnight, respectively.
Biochemical and cellular biology reagents. Mannan oligosaccharide (M-7504) and dextran oligo-
saccharide (CAS; 9004-54-0) were purchased from Sigma-Aldrich (St. Louis, MO) and Aladdin (Shanghai,
China), respectively. Anti-human DC-SIGN and mouse SIGNR1 monoclonal antibodies (MAbs) were
purchased from Pharmingen (San Diego, CA). LPS core of Neisseria gonorrhoeae was puriﬁed as described
previously (66). The bacteria were suspended in water and heated to 65°C. Equal volumes of phenol
heated to 65°C were added to the bacterial suspensions, and the mixture was incubated at 65°C for 1 h
with stirring. After centrifugation, the aqueous phase was recovered and the interfacial/phenol phase
material was reextracted once with water. Aqueous phases were ultraﬁltered three times through a
100-kDa ultraﬁltration device (Millipore), ultracentrifuged at 100,000  g for 6 h, and lyophilized.
Mice. C57BL/6, BALB/cJ, and LTR-1 KO mice in the C57BL/6 background (25) were bred in the animal
facility of UIC–College of Medicine and Tongji Hospital or purchased from Wuhan University Animal
Center. Mice were housed in animal facilities at the UIC–College of Medicine and Tongji Hospital in direct
accordance with guidelines drafted by the Animal Care Committees of UIC–College of Medicine–
Rockford and Tongji Hospital. The peritoneal macrophages express high levels of SIGNR1 (67, 68), as
shown in Fig. 9B.
Preparation of DCs. Peripheral blood mononuclear cells (PBMC) were isolated from buffy coats
obtained from human blood donors by density gradient centrifugation over FicollPaqueplus (1.077 g/ml;
Pharmacia, Piscataway, NJ). Blood was loaded in a 1:1 (vol/vol) ratio on Ficoll and centrifuged without
TABLE 1 Bacterial strains and cell lines used in this study
Strain or cell line Genotype (phenotype) or characteristic Reference or source
Y. pseudotuberculosis strains
Y1 Serotype O:1a, wild type expressing invasin, but with pYV plasmid naturally cured 74
PB1 Serotype O:1a, wild type 60
PB1ail ail::Kanr, Kmr, derivative of PB1 62
PB1ailinv PB1ail with the inv gene knockout This study
PB1wb Serotype O:1a, O-PS-negative derivative of PB1, Kanr 29
PB1wbailinv PB1wb strain with the ail and inv gene double KO This study
Y1/pBR322 Y1 with pBR322 plasmid; O-ag expression suppressed at 37°C This study
Y1/pAY100.1 Y1 with pAY100.1 plasmid expressing Y. enterocolitica O:3 O-ag This study
Y1/pBR322-mCherry Y1/pBR322 with mCherry plasmid This study
Y1/pAY100.1-mCherry Y1/pAY100.1 with mCherry plasmid This study
YPIII Serotype O:3 37
E. coli K-12 strains
CS180 Wild type 54–56
CS1861 CS180-O antigen
S17-1 pir thi pro hsdR hsdM recA::RP4-2-Tc::-Km::Tn7 strR (pir) 62
Cell lines
HeLa-NEO Control cell line, which expresses the neomycin resistance gene only
HeLa-DC-SIGN Generated by transfecting HeLa cells with human DC-SIGN cDNAs for stable surface expression
CHO-NEO Control cell line, which expresses the neomycin resistance gene only
CHO-SIGNR1 Generated by transfecting CHO cells with mouse SIGNR1 cDNAs for stable surface expression
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braking for 30 min. PBMC were washed 4 times with phosphate-buffered saline (PBS), and monocytes
were puriﬁed from PBMC using CD14 microbeads (Miltenyi Biotec, Auburn, CA), as previously described
(69). To increase purity, cells were passed over a second CD14 microbead column. The ﬁnal purity of the
isolated monocytes was 98%, as assessed by labeling with CD14-ﬂuorescein isothiocyanate (FITC)
antibody (Caltag, Carlsbad, CA) and ﬂow cytometric analysis. Puriﬁed CD14 monocytes (5 105
cells/ml) were cultured for 6 days to promote differentiation of immature monocyte-derived DCs
(MDDCs) in culture medium consisting of RPMI 1640 (BioWhittaker, Walkersville, MD), 10% heat-
inactivated fetal bovine serum (FBS) (HyClone, Logan, UT), 100 U/ml penicillin, and 100 g/ml strepto-
mycin in the presence of 20 ng/ml recombinant human granulocyte macrophage colony-stimulating
factor (Immunex, Seattle, WA) and 10 ng/ml recombinant human interleukin-4 (Peprotech, Rock Hill, NJ).
The DCs derived from these cultured monocytes display typical dendrites, and in mixed lymphocyte
cultures they promote activation of alloreactive T cells. The phenotypes of these cells are HLA-DR,
CD1a, CD86, CD40, and CD14 (69). Upon LPS stimulation, these DCs express CD83 (70). We have
utilized this protocol for identiﬁcation of DC-SIGN as a receptor for core LPS of several Gram-negative
bacteria and to explore how N. gonorrhoeae enhances HIV infection (14, 26, 31, 66).
Isolation of mouse peritoneal macrophages. After the mice were euthanized, the abdomens of
mice were immediately exposed, cleaned with 70% ethanol, and opened with scissors. Five milliliters of
RPMI was injected into the intraperitoneal cavity. Mouse abdomen was gently massaged for 2 min, and
then the lavage ﬂuid was collected. The suspension containing the macrophages was seeded onto 6-well
plates, in which each well contained a 1.5-cm-diameter glass coverslide, and placed in a CO2 incubator
for 2 h. The cell layers were washed 3 times to remove nonadherent cells. Macrophages were then
removed from the plastic surface by incubation with citrate saline and reseeded for interaction assays.
Cell lines. HeLa-hDC-SIGN cells were generated by transfecting HeLa cells with human DC-SIGN
cDNA, followed by selection for stable surface DC-SIGN expression, as originally described (71) (Table 1).
The cell lines were recently used for identiﬁcation of core LPS from several Gram-negative bacteria as the
ligand for the DC-SIGN receptor (14, 26, 33).
Mouse C-type lectin transfectant, CHO-mSIGNR1, was generated by transfecting CHO cells with
mouse SIGNR1 cDNAs, followed by selection for stable surface expression as originally described (67).
CHO-NEO is a control cell line which expresses the neomycin resistance gene only.
Adherence and phagocytosis assays. The adherence and phagocytosis assays were carried out as
described previously (59, 72). Brieﬂy, host cells (HeLa, CHO, dendritic cells, and human and mouse
macrophages) were plated in 24- or 96-well plates. Cells were suspended in RPMI with 2% fetal calf serum
(FCS) at a concentration of 4 105/ml. Aliquots (0.5 ml each) of these cell suspensions of were added to
24-well plates, and after addition of 50 l of bacterial suspensions at a concentration of 1 107 CFU/ml,
the cells were allowed to incubate for 2.5 h (2 h for dendritic cells and alveolar macrophages) at 37°C in
the presence of 5% CO2. The cell monolayers were then washed 3 times with PBS. The number of
associated bacteria (adherent and internalized) per cell was quantiﬁed by washing the cells 3 times with
RPMI containing 2% FCS and plating the culture after the cells were lysed by 0.5% saponin (Calbiochem
Corp., San Diego, CA).
To determine the internalization of bacteria, gentamicin, which kills extracellular bacteria but cannot
penetrate into host cells, was added into each well to a ﬁnal concentration of 100 g/ml, and the cultures
were incubated for 60 min. Cells were washed twice to remove the antibiotic (for DCs, a cytospin was
necessary during the washing, since DCs do not attach to plastic wells). Cells were suspended in PBS
containing 0.5% saponin, diluted, and plated on GC or LB plates. The level of internalization of bacteria
in these host cells was calculated by determining the CFU recovered from lysed cells. All experiments
were performed in triplicate, and data are expressed as means  standard errors.
Determination of phagocytosis by ﬂow cytometry. The following method was used to supple-
ment the survival-based phagocytosis assay described above, since DCs kill some phagocytosed bacteria,
such as Neisseria gonorrhoeae (14, 33, 34). Measurement of the phagocytosis rate of bacteria by DCs was
performed as follows. Brieﬂy, bacteria were suspended in RPMI medium containing 5- and 6-carboxy-
ﬂuorescein diacetate-succinimidyl ester (CFDA-SE; Molecular Probes, Eugene, OR) for 40 min and washed
2 times with RPMI to remove the excess dye. Labeled bacteria were added to DC cultures for 2 h. Cell
cultures were washed 2 times to remove unbound bacteria. DCs plus associated bacteria were ﬁxed with
2% paraformaldehyde. Before ﬂow cytometry, a 1:10 dilution of Trypan blue (0.4%, Sigma, St. Louis, MO)
was added to the ﬁxed cell cultures, and the mixture was incubated at ambient temperature for 10 min
(33) to quench the ﬂuorescence from extracellular labeled bacteria. Trypan blue blocks ﬂuorescence but
cannot penetrate host cells; therefore, ﬂuorescence from internalized bacteria will not be inﬂuenced by
addition of Trypan blue. The rate of bacterial internalization was determined by comparing the percent-
age of ﬂuorescence-positive DCs with that of DCs interacting with unlabeled bacteria.
In vivo phagocytosis assays for peritoneal macrophages. The protocol for the in vivo phagocytosis
assay is derived from a similar procedure from our previous studies on alveolar macrophages (34). In
detail, 1 ml of bacterial suspension (optical density at 600 nm [OD600] of 0.1) was injected into the mouse
intraperitoneal cavity. Mouse abdomen was gently massaged for 1 min. After 1.5 h, mice were eutha-
nized, another 4 ml of RPMI with 2% FCS was immediately injected into each mouse intraperitoneal
cavity, and the abdomen was gently massaged for another 1 min. The intraperitoneal ﬂuids or exudates
were collected, and the numbers of cells were counted for each collection of intraperitoneal lavage. A
total of 1 106 cells were seeded onto each well of 24-well plates, containing RPMI with 2% FCS and
gentamicin at a concentration of 100 g/ml, and were then incubated for 1.5 h to allow the macrophages
to adhere to plates and kill the extracellular bacteria. Each well was washed three times with RPMI with
Y. pseudotuberculosis Interacts with CD209 for Spreading Infection and Immunity
January 2019 Volume 87 Issue 1 e00654-18 iai.asm.org 13
 o
n
 January 9, 2019 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
2% FCS to remove nonadhered cells and lysed with saponin by following the same procedures as those
for the in vitro phagocytosis assays described above.
Animal challenging for dissemination and infection. C57BL/6, BALB/cJ, and LTR-1 KO mice in the
C57BL/6 background (25) were used in the following experiments. The dissemination rate was deﬁned
as the transport of Y. pseudotuberculosis to MLNs, livers, and spleens of the mice. The infectivity was
deﬁned as the body weight loss and the mortality after inoculations of pathogens.
In detail, mice were inoculated with Y. pseudotuberculosis at an OD600 of 1.0 in phosphate-buffered
saline (0.3 ml) via the orogastric route with a catheter. In experiments with strains Y1/pBR322 and
Y1/pAY100.1, mice were injected intravenously with 50 g/g ampicillin on each of the following days. At
72 h postinoculation, mice were euthanized and MLNs, livers, and spleens were collected and homog-
enized. It should be noted that MLNs isolated here included whole mesentery tissues. (i) For CFU
determination, the homogenized organs were lysed with 1% Triton X-100 to release the bacteria 10 min
before they were plated onto LB agar containing ampicillin. The numbers of CFU per organ were
determined as described previously (34). (ii) For real-time PCR assay, after 8 h of inoculation, total DNA
was isolated from the tissue-homogenized samples recovered from mice infected with Y. pseudotuber-
culosis. A standard dilution series of puriﬁed genomic Y. pseudotuberculosis DNA at concentrations of 108,
107, 106, 105, 104, 103, 102, 10, and 1 copies/l was used for quantiﬁcation. The standard dilution series
was included in all PCR runs. Primers ampliﬁed a 157-bp fragment from the ail gene and were the
following: forward, CGTCTGTTAATGTGTATGCCGAAG; reverse, GAACCTATCACTCCCCAGTCATTATT.
The real-time PCR was performed with a SYBR Green master mix and detected with a LightCycler (73).
The threshold cycle of each sample was measured for two replicates, and the DNA concentrations were
calculated using the LightCycler software. (iii) For in vivo imaging, Y1/pBR322-mCherry and Y1/pAY100.1-
mCherry, derived from Y1/pBR322 and Y1/pAY100.1, respectively, were used. The IVIS Spectrum in vivo
imaging system detected the mCherry ﬂuorescent protein with ﬁlters covering its excitation and
emission wavelengths at 587 nm and 610 nm. To better deﬁne the infected areas, the individual organs,
instead of whole mouse body, were collected and detected under the imaging system. Two points
should be noted. First, 30 min before inoculation, mice were injected with ampicillin at a ﬁnal concen-
tration of 50 g/g of mouse body weight to maintain the plasmid-based expression of O-antigen in
Y1/pAY100.1. Second, the Y. pseudotuberculosis strains used in this study were cultured at 26°C in order
to get effective invasion of mucosal surfaces. As mentioned in Discussion, the expression of invasin is
inhibited at 37°C (28). (iv) For the animal challenge assay, after growth at 37°C, wild-type Y. pseudotu-
berculosis YPIII, pretreated with and without oligosaccharides, was inoculated at an OD600 of 0.2 in a
manner similar to that described for the in vivo dissemination assay. The rates of body weight and death
of the mice were recorded every 12 h up to 156 h postinfection.
Statistical analyses. All statistical analyses were completed using Prism software, version 6 (Graph
Pad, San Diego, CA, USA). Statistical signiﬁcance was assessed using Student’s t test for the univariate
analysis of two sets of data and two-way analysis of variance (ANOVA) for multiple comparisons; for
mouse survival experiments (Fig. 11B), we used the log-rank test.
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